Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options

In connection with the New York Times’ recent coverage of hormone therapy1, Pfizer Inc. released important facts and context to respond to the newspaper’s account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines. Premarin (conjugated estrogens tablets USP) and Prempro (conjugated estrogens/medroxyprogesterone acetate tablets), which are approved by the Food and Drug Administration (FDA), have brought relief to tens of millions of women for decades…

Go to Source

People who read this also read

• CEA-Leti Announces TARGET-PDT Study Aimed At Improving Photodynamic Therapy For Cancer Treatment
  CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy (PDT) for treating cancer by developing a novel nano carrier-based approach. PDT is a minimally invasive treatment that destroys cancer cells with a combination of a photoact...
• Treatment Options For Generalized Anxiety Disorder
  A little worry is normal, but people who constantly worry about daily concerns, even when times are good, may have generalized anxiety disorder (GAD). GAD is excessive worry that lasts at least six months and disrupts daily activities, according to the March issue of Mayo Clinic Women's HealthSource...
• NICE Draft Guidance Proposes Treatment Options For Psoriatic Arthritis
  The National Institute for Health and Clinical Excellence (NICE) has published draft guidance recommending etanercept (Enbrel, Wyeth Pharmaceuticals) and adalimumab (Humira, Abbott Laboratories) for the treatment of adults with active and progressive psoriatic arthritis when specific criteria are me...
• Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options
  As the incidence of diabetes and hypertension continues to grow worldwide - and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems - the need for early patient education about kidney disease and treatment options, includi...
• WHO Releases New Malaria Guidelines For Treatment And Procurement Of Medicines
  The World Health Organization (WHO) is releasing new guidelines for the treatment of malaria, and the first ever guidance on procuring safe and efficacious anti-malarial medicines. In recent years a new type of treatment called artemisinin-based combination therapy (ACTs) has transformed the treatm...